User profiles for J. Rudd

James HF Rudd

Cambridge University
Verified email at cam.ac.uk
Cited by 17440

[HTML][HTML] Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans

…, Z Teng, E Gkrania-Klotsas, JHF Rudd… - Nature Machine …, 2021 - nature.com
Abstract Machine learning methods offer great promise for fast and accurate detection and
prognostication of coronavirus disease 2019 (COVID-19) from standard-of-care chest …

PET imaging of inflammation in atherosclerosis

JM Tarkin, FR Joshi, JHF Rudd - Nature Reviews Cardiology, 2014 - nature.com
PET imaging of atherosclerosis can quantify several in vivo pathological processes occurring
within the arterial system. F-fluorodeoxyglucose (FDG) is the most-commonly used PET …

Imaging atherosclerosis

…, AJ Brown, A Tawakol, ZA Fayad, JHF Rudd - Circulation …, 2016 - Am Heart Assoc
Advances in atherosclerosis imaging technology and research have provided a range of
diagnostic tools to characterize high-risk plaque in vivo; however, these important vascular …

Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography

JHF Rudd, EA Warburton, TD Fryer, HA Jones… - Circulation, 2002 - Am Heart Assoc
Background— Atherosclerotic plaque rupture is usually a consequence of inflammatory cell
activity within the plaque. Current imaging techniques provide anatomic data but no …

[HTML][HTML] 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial

…, NLM Cruden, NL Mills, KAA Fox, JHF Rudd… - The Lancet, 2014 - thelancet.com
Background The use of non-invasive imaging to identify ruptured or high-risk coronary
atherosclerotic plaques would represent a major clinical advance for prevention and treatment of …

Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial

…, CM Ballantyne, EA Stein, JC Tardif, JHF Rudd… - The Lancet, 2011 - thelancet.com
Background Dalcetrapib modulates cholesteryl ester transfer protein (CETP) activity to raise
high-density lipoprotein cholesterol (HDL-C). After the failure of torcetrapib it was unknown if …

18Fluorodeoxyglucose Positron Emission Tomography Imaging of Atherosclerotic Plaque Inflammation Is Highly Reproducible: Implications for Atherosclerosis …

JHF Rudd, KS Myers, S Bansilal, J Machac… - Journal of the American …, 2007 - jacc.org
Objectives : This study tested the near-term reproducibility of 18 fluorodeoxyglucose positron
emission tomography (FDG-PET) imaging of atherosclerosis. Background : It is known that …

Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology

…, G McKillop, EJR van Beek, NA Boon, JHF Rudd… - Journal of the American …, 2012 - jacc.org
Objectives : With combined positron emission tomography and computed tomography (CT),
we investigated coronary arterial uptake of 18F-sodium fluoride (18F-NaF) and 18F-…

Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations

JHF Rudd, KS Myers, S Bansilal… - Journal of Nuclear …, 2008 - Soc Nuclear Med
Atherosclerosis imaging with 18 F-FDG PET is useful for tracking inflammation within plaque
and monitoring the response to drug therapy. Short-term reproducibility of this technique in …

[HTML][HTML] Identifying active vascular microcalcification by 18F-sodium fluoride positron emission tomography

…, MR Bennett, KM Brindle, DE Newby, JH Rudd… - Nature …, 2015 - nature.com
Vascular calcification is a complex biological process that is a hallmark of atherosclerosis.
While macrocalcification confers plaque stability, microcalcification is a key feature of high-risk …